# Continuation of Drug Supply in Chinese Patients After CAMN107DBR01study Termination

> **NCT01613053** · — · NO_LONGER_AVAILABLE · sponsor: **Novartis Pharmaceuticals**

## Conditions studied

- Gastrointestinal Stromal Tumor

## Interventions

- **DRUG:** Glivec

## Key facts

- **NCT ID:** NCT01613053
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2015-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01613053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01613053, "Continuation of Drug Supply in Chinese Patients After CAMN107DBR01study Termination". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01613053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*